{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:55:46Z","timestamp":1781639746504,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Heidelberg der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Patients with Idiopathic Pulmonary Fibrosis (IPF) often have an unfavourable body composition, characterized by a reduced phase angle (PhA) as an index of cellular health and associated with increased mortality. Little is known about body composition in other subtypes of pulmonary fibrosis (PF). In this single-centre, prospective study, bioelectrical impedance analysis (BIA) was used to assess body composition in patients with PF. In addition, metabolic parameters, lung function, exercise capacity and quality of life (QoL) questionnaires were collected. The fibrosis index (FIBI) was calculated by quantitative computed tomography. A total of 90 patients (57.8% male, mean age 70.8\u2009\u00b1\u20098.9 years) was analysed. Lung function was mildly impaired with a mean forced vital capacity (FVC) of 76.8\u2009\u00b1\u200921.4% predicted and mean diffusion capacity for carbon monoxide single breath (DLCO-SB) of 49.5\u2009\u00b1\u200916.0% predicted. The mean FIBI was 22.5% (SD 10.2). Main diagnoses were systemic autoimmune rheumatic diseases-associated ILD (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200926, 29.9%), unclassified ILD (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200919, 21.1%) and fibrosing hypersensitivity pneumonitis (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200914, 15.6%). 22 patients (24.4%) received steroids and 26 (28.9%) other immunosuppressants. 22 patients (24.4%) experienced\u2009\u2265\u20091 acute exacerbation (AE). The mean body weight was 84.5\u2009\u00b1\u200918.2\u00a0kg with a mean body mass index (BMI) of 28.6\u2009\u00b1\u20095.7\u00a0kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    . One patient was underweight, and 31 patients (34.4%) had lost weight during the previous 6 months. BIA showed unfavourable values compared to healthy controls: body fat \u2191 (28.9\u2009\u00b1\u20098.0%), extracellular mass\/ body cell mass (ECM\/BCM) index \u2191 (1.2; IQR 1.0, 1.4), PhA \u2193 (4.9\u2009\u00b1\u20091.0\u00b0), cell percentage \u2193 (45.4\u2009\u00b1\u20096.3%) and fat-free mass index \u2191 (19.9\u2009\u00b1\u20092.7\u00a0kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    ). Correlation analyses showed a moderate correlation between PhA and FVC (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). No relevant correlations were found between DLCO-SB, walking distance, FIBI, QoL and BIA parameters. Patients with \u2265\u20091 AE had a significantly worse PhA (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.030). In addition, a sex difference was observed with significantly worse values of PhA for women compared to men (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.036). Patients with PF had an unfavourable body composition with reduced PhA, reduced cell percentage and elevated ECM\/BCM index. Significantly lower PhA values were found in patients with \u2265\u20091 AE and in women. Following longitudinal and interventional confirmation of our results, future research aimed at improving body composition and patient outcomes for those with PF could be conducted.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-39350-5","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:17:08Z","timestamp":1772792228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of body composition with bioelectrical impedance analysis in different subtypes of pulmonary fibrosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Katharina","family":"Buschulte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Ehrhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"K\u00f6tter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina Abbasi","family":"Dezfouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Weinheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"H\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Polke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix F. J.","family":"Herth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"39350_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society, European Respiratory Society. American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","year":"2002","unstructured":"American Thoracic Society, European Respiratory Society. American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American thoracic society (ATS), and the European respiratory society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS executive Committee, June 2001. Am. J. Respir Crit. Care Med. 165, 277\u2013304. https:\/\/doi.org\/10.1164\/ajrccm.165.2.ats01 (2002).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"39350_CR2","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","volume":"29","author":"T Koudstaal","year":"2023","unstructured":"Koudstaal, T., Funke-Chambour, M., Kreuter, M., Molyneaux, P. L. & Wijsenbeek, M. S. Pulmonary fibrosis: From pathogenesis to clinical decision-making. Trends Mol. Med. 29, 1076\u20131087. https:\/\/doi.org\/10.1016\/j.molmed.2023.08.010 (2023).","journal-title":"Trends Mol. Med."},{"key":"39350_CR3","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu, G. et al. Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults: An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am. J. Respir Crit. Care Med. 205, e18\u201347. https:\/\/doi.org\/10.1164\/rccm.202202-0399ST (2022).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"39350_CR4","doi-asserted-by":"publisher","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","volume":"27","author":"V Cottin","year":"2018","unstructured":"Cottin, V. et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur. Respir Rev. 27, 180076. https:\/\/doi.org\/10.1183\/16000617.0076-2018 (2018).","journal-title":"Eur. Respir Rev."},{"key":"39350_CR5","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1001\/jama.2024.3669","volume":"331","author":"TM Maher","year":"2024","unstructured":"Maher, T. M. Interstitial lung disease: A review. JAMA 331, 1655\u20131665. https:\/\/doi.org\/10.1001\/jama.2024.3669 (2024).","journal-title":"JAMA"},{"key":"39350_CR6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S2213-2600(17)30383-1","volume":"5","author":"M Kreuter","year":"2017","unstructured":"Kreuter, M. et al. Palliative care in interstitial lung disease: Living well. Lancet Respir Med. 5, 968\u2013980. https:\/\/doi.org\/10.1016\/S2213-2600(17)30383-1 (2017).","journal-title":"Lancet Respir Med."},{"key":"39350_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12931-020-01459-0","volume":"21","author":"A-M Hoffmann-Vold","year":"2020","unstructured":"Hoffmann-Vold, A-M. et al. The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease. Respir Res. 21, 197. https:\/\/doi.org\/10.1186\/s12931-020-01459-0 (2020).","journal-title":"Respir Res."},{"key":"39350_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12931-019-1019-9","volume":"20","author":"SA Guler","year":"2019","unstructured":"Guler, S. A., Hur, S. A., Lear, S. A., Camp, P. G. & Ryerson, C. J. Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: A prospective cohort study. Respir Res. 20, 56. https:\/\/doi.org\/10.1186\/s12931-019-1019-9 (2019).","journal-title":"Respir Res."},{"key":"39350_CR9","unstructured":"Das BIA-Kompendium III. Data Input & Ausgabe https:\/\/data-input.de\/media\/pdf-deutsch\/Kompendium_III_Ausgabe_2009.pdf"},{"key":"39350_CR10","doi-asserted-by":"publisher","first-page":"e001039","DOI":"10.1136\/bmjresp-2021-001039","volume":"8","author":"FVC Machado","year":"2021","unstructured":"Machado, F. V. C. et al. Relationship between body composition, exercise capacity and health-related quality of life in idiopathic pulmonary fibrosis. BMJ Open. Respir Res. 8, e001039. https:\/\/doi.org\/10.1136\/bmjresp-2021-001039 (2021).","journal-title":"BMJ Open. Respir Res."},{"key":"39350_CR11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/resp.12941","volume":"22","author":"O Nishiyama","year":"2017","unstructured":"Nishiyama, O. et al. Fat-free mass index predicts survival in patients with idiopathic pulmonary fibrosis. Respirology 22, 480\u2013485. https:\/\/doi.org\/10.1111\/resp.12941 (2017).","journal-title":"Respirology"},{"key":"39350_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ncp.10651","volume":"36","author":"S Rinaldi","year":"2021","unstructured":"Rinaldi, S. et al. Exercise capacity and its relationship with body composition and nutrition status in patients with interstitial lung disease. Nutr. Clin. Pract. 36, 891\u2013898. https:\/\/doi.org\/10.1002\/ncp.10651 (2021).","journal-title":"Nutr. Clin. Pract."},{"key":"39350_CR13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1055\/s-2004-813530","volume":"176","author":"T Achenbach","year":"2004","unstructured":"Achenbach, T. et al. [Fully automatic detection and quantification of emphysema on thin section MD-CT of the chest by a new and dedicated software]. Rofo 176, 1409\u20131415. https:\/\/doi.org\/10.1055\/s-2004-813530 (2004).","journal-title":"Rofo"},{"key":"39350_CR14","doi-asserted-by":"publisher","first-page":"e0271787","DOI":"10.1371\/journal.pone.0271787","volume":"17","author":"TD Do","year":"2022","unstructured":"Do, T. D. et al. COVID-19 pneumonia: Prediction of patient outcome by CT-based quantitative lung parenchyma analysis combined with laboratory parameters. PLoS One. 17, e0271787. https:\/\/doi.org\/10.1371\/journal.pone.0271787 (2022).","journal-title":"PLoS One"},{"key":"39350_CR15","doi-asserted-by":"publisher","first-page":"107559","DOI":"10.1016\/j.rmed.2024.107559","volume":"223","author":"C Rott","year":"2024","unstructured":"Rott, C., Limen, E., Kriegsmann, K., Herth, F. & Brock, J. M. Analysis of body composition with bioelectrical impedance analysis in patients with severe COPD and pulmonary emphysema. Respir Med. 223, 107559. https:\/\/doi.org\/10.1016\/j.rmed.2024.107559 (2024).","journal-title":"Respir Med."},{"key":"39350_CR16","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober, P., Boer, C. & Schwarte, L. A. Correlation coefficients: Appropriate use and interpretation. Anesth. Analg. 126, 1763\u20131768. https:\/\/doi.org\/10.1213\/ANE.0000000000002864 (2018).","journal-title":"Anesth. Analg"},{"key":"39350_CR17","first-page":"69","volume":"24","author":"MM Mukaka","year":"2012","unstructured":"Mukaka, M. M. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med. J. 24, 69\u201371 (2012).","journal-title":"Malawi Med. J."},{"key":"39350_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.exger.2013.11.016","volume":"50","author":"B Saragat","year":"2014","unstructured":"Saragat, B. et al. Specific bioelectrical impedance vector reference values for assessing body composition in the Italian elderly. Exp. Gerontol. 50, 52\u201356. https:\/\/doi.org\/10.1016\/j.exger.2013.11.016 (2014).","journal-title":"Exp. Gerontol."},{"key":"39350_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.clnu.2025.10.021","volume":"55","author":"F Campa","year":"2025","unstructured":"Campa, F. et al. Determining body composition using different bioimpedance technologies: Is an agreement possible? Clin. Nutr. 55, 180\u2013188. https:\/\/doi.org\/10.1016\/j.clnu.2025.10.021 (2025).","journal-title":"Clin. Nutr."},{"key":"39350_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/0148607106030004309","volume":"30","author":"A Bosy-Westphal","year":"2006","unstructured":"Bosy-Westphal, A. et al. Phase angle from bioelectrical impedance analysis: Population reference values by age, sex, and body mass index. JPEN J. Parenter. Enter. Nutr. 30, 309\u2013316. https:\/\/doi.org\/10.1177\/0148607106030004309 (2006).","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"39350_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12890-022-01907-1","volume":"22","author":"N Mart\u00ednez-Luna","year":"2022","unstructured":"Mart\u00ednez-Luna, N. et al. Association between body composition, sarcopenia and pulmonary function in chronic obstructive pulmonary disease. BMC Pulm Med. 22, 106. https:\/\/doi.org\/10.1186\/s12890-022-01907-1 (2022).","journal-title":"BMC Pulm Med."},{"key":"39350_CR22","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.1111\/febs.70177","volume":"292","author":"S Bouffette","year":"2025","unstructured":"Bouffette, S. et al. Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis. FEBS J. 292, 6054\u20136074. https:\/\/doi.org\/10.1111\/febs.70177 (2025).","journal-title":"FEBS J."},{"key":"39350_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11306-025-02355-8","volume":"21","author":"F Faizee","year":"2025","unstructured":"Faizee, F. et al. Metabolomic profiling reveals distinct lipid signatures in progressive versus stable fibrotic lung disease. Metabolomics 21, 153. https:\/\/doi.org\/10.1007\/s11306-025-02355-8 (2025).","journal-title":"Metabolomics"},{"key":"39350_CR24","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.3390\/nu17243843","volume":"17","author":"A Tomasiewicz","year":"2025","unstructured":"Tomasiewicz, A., Targowski, T., Makuch, S., Pola\u0144ski, J. & Ta\u0144ski, W. The relationship between bioelectrical impedance analysis parameters and laboratory biomarkers in an elderly Polish cohort: A cross-sectional study. Nutrients 17, 3843. https:\/\/doi.org\/10.3390\/nu17243843 (2025).","journal-title":"Nutrients"},{"key":"39350_CR25","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/ejcn.2015.126","volume":"69","author":"O Grundmann","year":"2015","unstructured":"Grundmann, O., Yoon, S. L. & Williams, J. J. The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients\u2013a comprehensive review. Eur. J. Clin. Nutr. 69, 1290\u20131297. https:\/\/doi.org\/10.1038\/ejcn.2015.126 (2015).","journal-title":"Eur. J. Clin. Nutr."},{"key":"39350_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-319-70178-3_2","volume":"1043","author":"MA Bredella","year":"2017","unstructured":"Bredella, M. A. Sex differences in body composition. Adv. Exp. Med. Biol. 1043, 9\u201327. https:\/\/doi.org\/10.1007\/978-3-319-70178-3_2 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"39350_CR27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1378\/chest.13-1474","volume":"145","author":"CJ Ryerson","year":"2014","unstructured":"Ryerson, C. J. et al. Predicting survival across chronic interstitial lung disease: The ILD-GAP model. Chest 145, 723\u2013728. https:\/\/doi.org\/10.1378\/chest.13-1474 (2014).","journal-title":"Chest"},{"key":"39350_CR28","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1183\/09031936.00131912","volume":"42","author":"CJ Ryerson","year":"2013","unstructured":"Ryerson, C. J. et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur. Respir J. 42, 750\u2013757. https:\/\/doi.org\/10.1183\/09031936.00131912 (2013).","journal-title":"Eur. Respir J."},{"key":"39350_CR29","doi-asserted-by":"publisher","first-page":"00403","DOI":"10.1183\/23120541.00403-2024","volume":"10","author":"M Kreuter","year":"2024","unstructured":"Kreuter, M. et al. Acute exacerbations in patients with progressive pulmonary fibrosis. ERJ Open. Res. 10, 00403\u20132024. https:\/\/doi.org\/10.1183\/23120541.00403-2024 (2024).","journal-title":"ERJ Open. Res."},{"key":"39350_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/arm92030023","volume":"92","author":"A-N Xie","year":"2024","unstructured":"Xie, A-N., Huang, W-J. & Ko, C-Y. Extracellular water ratio and phase angle as predictors of exacerbation in chronic obstructive pulmonary disease. Adv. Respir Med. 92, 230\u2013240. https:\/\/doi.org\/10.3390\/arm92030023 (2024).","journal-title":"Adv. Respir Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39350-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:29:27Z","timestamp":1781638167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39350-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39350"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39350-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KB received payment for lectures and consulting from Apontis Pharma, Astra Zeneca, Boehringer Ingelheim, Chiesi, med update GmbH, streamedup! GmbH, and a grant from Sarkoidose-Netzwerk e.V., all outside the submitted work. BK received payment for lectures from Diaplan GmbH and conference fees from Boehringer Ingelheim, all outside the submitted work. OW declares that airway analysis technology is licensed to Imbio, L.L.C. and payment for lectures from Vertex Pharmaceuticals, these activities are outside the submitted work. PH received payment for lectures drom Grifols GmbH and CSL Behring, support for attending meetings from CSL Behring and Chiesi and a grant from CSL Behring, all outside the submitted work. MP received payment for lectures and consulting fees from Apontis Pharma, AstraZeneca, Boehringer Ingelheim and Novartis, all outside the submitted work. JB has received honoraria and consultation fees from Boehringer Ingelheim, Astra Zeneca, streamed up!, Intuitive Surgical Inc, Berlin Chemie, Olympus, Pulmonx, and Microtech. These activities are outside the submitted work. All other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted ethically in accordance with the World Medical Association Declaration of Helsinki and was approved by the Ethics Committee of the Medical Faculty of the University of Heidelberg, Germany (S-754\/2023). Informed consent to participate in the study was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"8495"}}